Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2012) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Frontiers in Pharmacology | journal | 0.717 Q2 | 154 | 206 | 129 | 17703 | 312 | 125 | 2.42 | 85.94 |  |
| 52 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.942 Q2 | 100 | 127 | 366 | 10730 | 1396 | 363 | 3.62 | 84.49 |  |
| 53 | Milestones in Drug Therapy | book series | 0.110 Q4 | 6 | 49 | 59 | 4127 | 7 | 58 | 0.12 | 84.22 |  |
| 54 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 27 | 65 | 2250 | 163 | 64 | 2.82 | 83.33 |  | |
| 55 | Pharmacogenomics and Personalized Medicine | journal | 0.150 Q4 | 37 | 11 | 31 | 914 | 13 | 31 | 0.55 | 83.09 |  |
| 56 | Expert Opinion on Therapeutic Targets | journal | 1.788 Q1 | 106 | 138 | 337 | 11271 | 1536 | 335 | 4.36 | 81.67 | |
| 57 | Journal of International Peacekeeping | journal | 0.138 Q4 | 14 | 15 | 50 | 1222 | 21 | 47 | 0.34 | 81.47 |  |
| 58 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.235 Q3 | 17 | 34 | 78 | 2748 | 37 | 70 | 0.39 | 80.82 | |
| 59 | Antibodies | journal | 42 | 17 | 0 | 1370 | 0 | 0 | 0.00 | 80.59 | | |
| 60 | Open Pharmacology Journal | journal | 0.201 Q3 | 6 | 5 | 10 | 400 | 11 | 10 | 1.80 | 80.00 | |
| 61 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 34 | 98 | 2712 | 252 | 95 | 2.60 | 79.76 | | |
| 62 | Open Neuropsychopharmacology Journal | journal | 0.183 Q3 | 6 | 3 | 20 | 238 | 11 | 19 | 0.38 | 79.33 | |
| 63 | Expert Opinion on Therapeutic Patents | journal | 1.330 Q1 | 88 | 100 | 339 | 7922 | 1229 | 333 | 3.47 | 79.22 | |
| 64 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.394 Q3 | 30 | 27 | 81 | 2124 | 126 | 80 | 1.75 | 78.67 | |
| 65 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.515 Q1 | 99 | 23 | 76 | 1791 | 447 | 75 | 4.75 | 77.87 | |
| 66 | Expert Opinion on Investigational Drugs | journal | 1.486 Q1 | 117 | 161 | 456 | 12444 | 2063 | 446 | 4.32 | 77.29 | |
| 67 | Neuropharmacology | journal | 2.315 Q1 | 191 | 408 | 798 | 31474 | 4103 | 782 | 4.39 | 77.14 | |
| 68 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 61 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | |
| 69 | Current Drug Discovery Technologies | journal | 0.801 Q2 | 49 | 34 | 94 | 2615 | 288 | 87 | 2.45 | 76.91 | |
| 70 | Clinical Pharmacokinetics | journal | 2.254 Q1 | 184 | 56 | 179 | 4291 | 1219 | 160 | 7.01 | 76.63 | |
| 71 | Pharmaceuticals | journal | 0.539 Q2 | 87 | 78 | 297 | 5945 | 500 | 293 | 1.70 | 76.22 | |
| 72 | Side Effects of Drugs Annual | book series | 0.102 Q4 | 9 | 53 | 157 | 4034 | 4 | 53 | 0.02 | 76.11 | |
| 73 | Neurotoxicity Research | journal | 1.217 Q1 | 84 | 68 | 245 | 5163 | 870 | 241 | 3.23 | 75.93 | |
| 74 | Toxin Reviews | journal | 0.328 Q3 | 54 | 7 | 56 | 531 | 72 | 54 | 1.00 | 75.86 | |
| 75 | Current Vascular Pharmacology | journal | 0.975 Q2 | 69 | 107 | 217 | 8016 | 744 | 205 | 3.15 | 74.92 | |
| 76 | Inflammation and Allergy - Drug Targets | journal | 0.973 Q2 | 55 | 66 | 153 | 4860 | 537 | 140 | 2.66 | 73.64 | |
| 77 | CNS and Neurological Disorders - Drug Targets | journal | 1.492 Q1 | 96 | 123 | 237 | 9055 | 913 | 208 | 3.68 | 73.62 | |
| 78 | Future Medicinal Chemistry | journal | 1.047 Q1 | 90 | 191 | 426 | 13920 | 1083 | 338 | 2.58 | 72.88 | |
| 79 | Clinical Medicine Insights: Therapeutics | journal | 0.109 Q4 | 11 | 22 | 83 | 1600 | 14 | 83 | 0.17 | 72.73 | |
| 80 | BioDrugs | journal | 1.106 Q1 | 79 | 42 | 130 | 3053 | 546 | 127 | 3.62 | 72.69 | |
| 81 | Therapeutic Advances in Neurological Disorders | journal | 0.789 Q2 | 68 | 28 | 93 | 1970 | 302 | 89 | 4.05 | 70.36 | |
| 82 | Toxicology Research | journal | 47 | 23 | 0 | 1605 | 0 | 0 | 0.00 | 69.78 | | |
| 83 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.183 Q3 | 27 | 35 | 109 | 2441 | 66 | 98 | 0.47 | 69.74 | |
| 84 | PPAR Research | journal | 0.830 Q2 | 59 | 86 | 117 | 5992 | 312 | 110 | 2.90 | 69.67 | |
| 85 | Toxins | journal | 0.731 Q2 | 116 | 89 | 259 | 6168 | 651 | 257 | 2.56 | 69.30 | |
| 86 | Therapeutic Delivery | journal | 0.357 Q2 | 63 | 130 | 213 | 8982 | 223 | 202 | 1.05 | 69.09 | |
| 87 | Current Psychopharmacology | journal | 4 | 1 | 0 | 69 | 0 | 0 | 0.00 | 69.00 | | |
| 88 | Trends in Pharmacological Sciences | journal | 5.103 Q1 | 244 | 86 | 251 | 5885 | 2971 | 237 | 10.51 | 68.43 | |
| 89 | Molecular Diagnosis and Therapy | journal | 0.540 Q2 | 68 | 37 | 109 | 2509 | 237 | 102 | 1.88 | 67.81 | |
| 90 | EPMA Journal | journal | 0.208 Q3 | 52 | 13 | 107 | 879 | 106 | 96 | 0.99 | 67.62 | |
| 91 | Journal of Cardiovascular Translational Research | journal | 1.198 Q1 | 60 | 84 | 239 | 5662 | 712 | 224 | 3.46 | 67.40 | |
| 92 | Current Drug Therapy | journal | 0.187 Q3 | 20 | 36 | 97 | 2407 | 47 | 91 | 0.36 | 66.86 | |
| 93 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 0.638 Q2 | 47 | 32 | 4 | 2137 | 6 | 3 | 1.50 | 66.78 | |
| 94 | Journal of NeuroImmune Pharmacology | journal | 1.510 Q1 | 91 | 92 | 167 | 6131 | 735 | 158 | 3.55 | 66.64 | |
| 95 | Open Toxicology Journal | journal | 0.118 Q4 | 8 | 2 | 15 | 132 | 7 | 15 | 0.38 | 66.00 | |
| 96 | British Journal of Pharmacology | journal | 1.811 Q1 | 244 | 556 | 1568 | 36364 | 7573 | 1499 | 5.12 | 65.40 | |
| 97 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.202 Q3 | 29 | 13 | 26 | 845 | 8 | 0 | 0.33 | 65.00 | |
| 98 | Current Bioactive Compounds | journal | 0.660 Q1 | 31 | 46 | 80 | 2983 | 121 | 71 | 0.83 | 64.85 | |
| 99 | Journal of Occupational Medicine and Toxicology | journal | 0.476 Q3 | 47 | 19 | 101 | 1232 | 168 | 100 | 1.74 | 64.84 | |
| 100 | Expert Opinion on Pharmacotherapy | journal | 0.756 Q2 | 93 | 251 | 812 | 16233 | 2240 | 780 | 2.71 | 64.67 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data